Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Steven R. Schneider"'
Autor:
Rebecca E. O’Connor, Steven R. Schneider, Denise Gautreau, Philip A. Carpino, Karen M. Ward, Jeffrey S. Lizano, John R. Hadcock, Philip A. Iredale, Dennis O. Scott, Robert L. Dow, Dawn Kelly-Sullivan
Publikováno v:
ACS Medicinal Chemistry Letters. 3:397-401
Antagonism of cannabinoid-1 (CB1) receptor signaling has been demonstrated to inhibit feeding behaviors in humans, but CB1-mediated central nervous system (CNS) side effects have halted the marketing and further development of the lead drugs against
Publikováno v:
Tetrahedron Letters. 52:5417-5420
This Letter describes the first report of a highly stereoselective synthesis of triethereal cyclohexanones via copper(I) mediated 1,4-addition of organometallic reagents to glucose-derived triethereal cyclohexenone. The cyclohexanones generated can b
Autor:
Marlys Hammond, David A. Griffith, Philip A. Carpino, Steven R. Schneider, Robert L. Dow, Paul DaSilva-Jardine, John R. Hadcock, Philip A. Iredale, Dennis O. Scott, Ernest S. Paight
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 19:5351-5354
A new series of CB(1) receptor antagonists incorporating an imidazole-based isosteric replacement for the hydrazide moiety of rimonabant (SR141716) is disclosed. Members of this imidazole series possess potent/selective binding to the rCB(1) receptor
Autor:
Robert L. Dow, Paul DaSilva-Jardine, Ernest S. Paight, Philip A. Carpino, David A. Griffith, John R. Hadcock, Philip A. Iredale, Dennis O. Scott, Rebecca E. O’Connor, Chudy I. Nduaka, Shawn C Black, Steven R. Schneider
Publikováno v:
Journal of Medicinal Chemistry. 52:2652-2655
We report the design, synthesis, and structure-activity relationships of novel bicyclic lactam-based cannabinoid type 1 (CB(1)) receptor antagonists. Members of these series are potent, selective antagonists in in vitro/in vivo efficacy models of CB(
Autor:
Paul DaSilva-Jardine, Josephine Spitzer, Michele H. Rosner, Samuel P. Simons, Diane M. Hargrove, Boris A. Chrunyk, Richard F. Hank, Phoebe Chiang, Ernest S. Paight, Swick Andrew Gordon, Robert L. Dow, Peter Cornelius, Gayle K. Schulte, Tate Bonnie Frances, Steven R. Schneider, Terrell A. Patterson, William P. Newsome, Jayvardhan Pandit, Mark Ammirati, Eunsun Lee, Dennis E. Danley, Peter K. LeMotte
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 13:379-382
In this communication, we wish to describe the discovery of a novel series of 6-azauracil-based thyromimetics that possess up to 100-fold selectivities for binding and functional activation of the beta(1)-isoform of the thyroid receptor family. Struc
Publikováno v:
SSRN Electronic Journal.
This article examines the alternative forms available to merging tax partnerships and reveals how the different forms can affect the tax consequences of the parties to such a transaction. In particular, the article illustrates how parties should choo
Autor:
Robert L. Dow, Steven R. Schneider
Publikováno v:
Journal of Heterocyclic Chemistry. 38:535-537
The 5,6,7,8-tetrahydro-1,7-naphthyridine (7) pharmacophore has the potential to serve as a confor-mationally-locked analog of the pharmacologically active 2-(3-pyridyl)ethylamine (1) core structure. This paper describes the synthesis of 5,6,7,8-tetra
Autor:
Steven R. Schneider, Robert L. Dow
Publikováno v:
ChemInform. 32